Value proposition

Belgium biotech company providing unique pipeline of medical devices in OsteoArthritis, skin aging and ophthalmology.

Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high impact pathologies and major social burdens such as invalidating OsteoArthritis, skin aging and ophthalmology.

Medical Devices & Implants, Biomaterials, Rheumatology & Joint Health, Dermatology, Biosurgery, Regenerative Medicine, Ultrapure Chitosan, and Animal-free Chitosan